Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhixian Yu

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|September 13, 2024
Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysisShihui Lv, Qian Guo, Yuhan He, et al.
Peerj|September 22, 2022
Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancerMin Weng, Chenghao Shi, Hui Han, et al.
Journal of Cellular and Molecular Medicine|September 4, 2023
Glucose dysregulation promotes oncogenesis in human bladder cancer by regulating autophagy and YAP1/TAZ expressionShi Li, Banzhan Ruan, Zhi Wang, et al.
Urology|November 16, 2016
Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled TrialHongde Chen, Feng Wang, Zhixian Yu, et al.
Clinical Epigenetics|December 20, 2025
Novel DNA methylation biomarkers in urine for non-invasive diagnosis of bladder urothelial carcinomaCong Shi, Jianglei Xu, Qinyu Chen, et al.
Frontiers in Genetics|September 29, 2022
Development and validation of a novel necroptosis-related score to improve the outcomes of clear cell renal cell carcinomaJi Chen, Qiqi Tao, Zhichao Lang, et al.
International Urology and Nephrology|September 17, 2014
Docetaxel with or without zoledronic acid for castration-resistant prostate cancerYue Pan, Haiyong Jin, Wei Chen, et al.
Frontiers in Oncology|July 10, 2023
Genomic profiles of renal cell carcinoma in a small Chinese cohortSheng Tai, Dan-Dan Xu, Zhixian Yu, et al.
Cancer Medicine|October 10, 2025
Distinct Clinicopathological Features of HER2-Negative, HER2-Low, and HER2-Overexpressing Urothelial Carcinoma in a Large Chinese CohortShanshan Wang, Dingwei Ye, Li Yang, et al.
Journal of Cancer|September 11, 2020
Association of preoperative systemic Immune-inflammation Index and Prognostic Nutritional Index with survival in patients with Upper Tract Urothelial CarcinomaYangqin Zheng, Dongdong Yu, Zhixian Yu, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|September 13, 2024
Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysisShihui Lv, Qian Guo, Yuhan He, et al.
Peerj|September 22, 2022
Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancerMin Weng, Chenghao Shi, Hui Han, et al.
Journal of Cellular and Molecular Medicine|September 4, 2023
Glucose dysregulation promotes oncogenesis in human bladder cancer by regulating autophagy and YAP1/TAZ expressionShi Li, Banzhan Ruan, Zhi Wang, et al.
Urology|November 16, 2016
Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled TrialHongde Chen, Feng Wang, Zhixian Yu, et al.
Clinical Epigenetics|December 20, 2025
Novel DNA methylation biomarkers in urine for non-invasive diagnosis of bladder urothelial carcinomaCong Shi, Jianglei Xu, Qinyu Chen, et al.
Frontiers in Genetics|September 29, 2022
Development and validation of a novel necroptosis-related score to improve the outcomes of clear cell renal cell carcinomaJi Chen, Qiqi Tao, Zhichao Lang, et al.
International Urology and Nephrology|September 17, 2014
Docetaxel with or without zoledronic acid for castration-resistant prostate cancerYue Pan, Haiyong Jin, Wei Chen, et al.
Frontiers in Oncology|July 10, 2023
Genomic profiles of renal cell carcinoma in a small Chinese cohortSheng Tai, Dan-Dan Xu, Zhixian Yu, et al.
Cancer Medicine|October 10, 2025
Distinct Clinicopathological Features of HER2-Negative, HER2-Low, and HER2-Overexpressing Urothelial Carcinoma in a Large Chinese CohortShanshan Wang, Dingwei Ye, Li Yang, et al.
Journal of Cancer|September 11, 2020
Association of preoperative systemic Immune-inflammation Index and Prognostic Nutritional Index with survival in patients with Upper Tract Urothelial CarcinomaYangqin Zheng, Dongdong Yu, Zhixian Yu, et al.
Pageof 6